Literature DB >> 17619134

Antigenic characterisation of yeast-expressed lyssavirus nucleoproteins.

Indre Kucinskaite1, Mindaugas Juozapaitis, Andrius Serva, Aurelija Zvirbliene, Nicholas Johnson, Juozas Staniulis, Anthony R Fooks, Thomas Müller, Kestutis Sasnauskas, Rainer G Ulrich.   

Abstract

In Europe, three genotypes of the genus Lyssavirus, family Rhabdoviridae, are present, classical rabies virus (RABV, genotype 1), European bat lyssavirus type 1 (EBLV-1, genotype 5) and European bat lyssavirus type 2 (EBLV-2, genotype 6). The entire authentic nucleoprotein (N protein) encoding sequences of RABV (challenge virus standard, CVS, strain), EBLV-1 and EBLV-2 were expressed in yeast Saccharomyces cerevisiae at high level. Purification of recombinant N proteins by caesium chloride gradient centrifugation resulted in yields between 14-17, 25-29 and 18-20 mg/l of induced yeast culture for RABV-CVS, EBLV-1 and EBLV-2, respectively. The purified N proteins were evaluated by negative staining electron microscopy, which revealed the formation of nucleocapsid-like structures. The antigenic conformation of the N proteins was investigated for their reactivity with monoclonal antibodies (mAbs) directed against different lyssaviruses. The reactivity pattern of each mAb was virtually identical between immunofluorescence assay with virus-infected cells, and ELISA and dot blot assay using the corresponding recombinant N proteins. These observations lead us to conclude that yeast-expressed lyssavirus N proteins share antigenic properties with naturally expressed virus protein. These recombinant proteins have the potential for use as components of serological assays for lyssaviruses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17619134     DOI: 10.1007/s11262-007-0127-7

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  41 in total

1.  Yeast cells allow high-level expression and formation of polyomavirus-like particles.

Authors:  K Sasnauskas; O Buzaite; F Vogel; B Jandrig; R Razanskas; J Staniulis; S Scherneck; D H Krüger; R Ulrich
Journal:  Biol Chem       Date:  1999-03       Impact factor: 3.915

2.  Morphology of Marburg virus NP-RNA.

Authors:  Manos Mavrakis; Larissa Kolesnikova; Guy Schoehn; Stephan Becker; Rob W H Ruigrok
Journal:  Virology       Date:  2002-05-10       Impact factor: 3.616

3.  Monoclonal antibody characterization of rabies virus isolates from Russia, Finland and Estonia.

Authors:  A E Metlin; J Cox; S S Rybakov; A Huovilainen; K N Grouzdev; E Neuvonen
Journal:  J Vet Med B Infect Dis Vet Public Health       Date:  2004-03

4.  Circular and elongated linear forms of measles virus nucleocapsid.

Authors:  H V THorne; E Dermott
Journal:  Nature       Date:  1976-12-02       Impact factor: 49.962

5.  Protection of mice with vaccinia virus recombinants that express the rabies nucleoprotein.

Authors:  J W Sumner; M Fekadu; J H Shaddock; J J Esposito; W J Bellini
Journal:  Virology       Date:  1991-08       Impact factor: 3.616

6.  Structure of the vesicular stomatitis virus nucleoprotein-RNA complex.

Authors:  Todd J Green; Xin Zhang; Gail W Wertz; Ming Luo
Journal:  Science       Date:  2006-06-15       Impact factor: 47.728

7.  Generation of Sendai virus nucleocapsid-like particles in yeast.

Authors:  Mindaugas Juozapaitis; Rimantas Slibinskas; Juozas Staniulis; Takemasa Sakaguchi; Kestutis Sasnauskas
Journal:  Virus Res       Date:  2005-03       Impact factor: 3.303

8.  Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae.

Authors:  K Sasnauskas; A Bulavaite; A Hale; L Jin; W A Knowles; A Gedvilaite; A Dargeviciūte; D Bartkeviciūte; A Zvirbliene; J Staniulis; D W G Brown; R Ulrich
Journal:  Intervirology       Date:  2002       Impact factor: 1.763

9.  Measles virus nucleocapsid protein expressed in insect cells assembles into nucleocapsid-like structures.

Authors:  A R Fooks; J R Stephenson; A Warnes; A B Dowsett; B K Rima; G W Wilkinson
Journal:  J Gen Virol       Date:  1993-07       Impact factor: 3.891

10.  Development of a measles specific IgM ELISA for use with serum and oral fluid samples using recombinant measles nucleoprotein produced in Saccharomyces cerevisiae.

Authors:  Dhanraj Samuel; Kestutis Sasnauskas; Li Jin; Alma Gedvilaite; Rimas Slibinskas; Stuart Beard; Aurelija Zvirbliene; Solange Artimos Oliveira; Juozas Staniulis; Bernard Cohen; David Brown
Journal:  J Clin Virol       Date:  2003-10       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.